GlassScriptPhysician profile
Amy Van Amburgh
NPI 1972111854
$5,922.72
in general payments reported to CMS, 2019-2025
21 companies · $532 in 2025
The $532 reported for 2025 was more than what 75% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $68.90 · 2022: $1,304 · 2023: $2,534 · 2024: $1,484 · 2025: $532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,865 · Travel and Lodging: $684 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,865.17 |
| Travel and Lodging | $683.56 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $3,223.01 | 2021-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abiomed | $359.02 | 2022-2024 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $305.04 | 2022-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $245.90 | 2022-2023 | Farxiga |
| Galderma Laboratories, L.P. | $237.44 | 2024-2025 | Dysport |
| Novartis Pharmaceuticals Corporation | $179.59 | 2022 | |
| Chiesi USA, INC. | $168.67 | 2021-2023 | Kengreal |
| Amgen INC. | $162.64 | 2021-2022 | |
| Abbvie INC. | $125.00 | 2025 | |
| Akebia Therapeutics INC | $121.84 | 2025 | Vafseo |
| Acacia Pharma INC | $120.08 | 2022 | |
| Medtronic, INC. | $118.29 | 2022-2024 | Onyx Frontier |
| E.R. Squibb & Sons, L.L.C. | $115.71 | 2023 | Camzyos |
| Actelion Pharmaceuticals US, INC. | $103.02 | 2023 | Uptravi, Opsumit |
| Pfizer INC. | $84.39 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $79.96 | 2024-2025 | Xience Skypoint, Perclose Prostyle |
| Janssen Pharmaceuticals, INC | $60.73 | 2022-2024 | Xarelto |
| Esperion Therapeutics, INC. | $34.67 | 2022 | |
| Becton, Dickinson and Company | $33.55 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $31.48 | 2024 | Lifevest |
| Silk Road Medical, INC. | $12.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Van Amburgh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.